Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

3 buys whatever the EU referendum result: AstraZeneca plc, YouGov plc and Cobham plc

These three stocks look set to perform well whether Leave or Remain win today’s vote: AstraZeneca plc (LON: AZN), YouGov plc (LON: YOU) and Cobham plc (LON: COB).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So, the EU referendum is finally upon us and many investors may be wondering which stocks are set to perform well given a Remain or Leave victory. Certainly, there are many examples of potential winners given either result, but there are also stocks that could be set to record stunning share price gains whether the UK stays in or quits the EU.

One such is AstraZeneca (LSE: AZN). Its status as an international pharmaceutical company means that it’s more dependent on the ups and downs of the patent cycle rather than the booms and busts of the UK economy. And on the patent front it appears to be making strong progress with its acquisition strategy improving AstraZeneca’s treatment pipeline so that it’s on track to return to positive earnings growth over the medium term.

Furthermore, AstraZeneca is unlikely to slow down its pace of acquisitions, with the company having excellent cash flow, which affords it tremendous financial firepower. For example, in the last three years AstraZeneca’s free cash flow has averaged $4.9bn per annum and so it seems able to afford to spend further in order to beef up its pipeline. And with that cash flow supporting a yield of 5%, the company’s income potential remains upbeat – especially while interest rates are at rock bottom.

Headline grabber

Also offering upbeat future prospects whatever the EU referendum result is YouGov (LSE: YOU). Clearly, it has been in the headlines a lot more than usual recently, with its polling segment offering up predictions of whether Leave or Remain will win the vote. This could provide a boost to YouGov’s earnings in the short run and with the company expected to increase its net profit by 11% this year and by a further 13% next year, it seems to be performing well.

In fact, YouGov has an excellent track record of earnings growth, with its bottom line rising in each of the last five financial years. And with its shares trading on a price-to-earnings growth (PEG) ratio of just 1.6, they seem to offer a wide margin of safety for long-term investors. Therefore, whether the UK leaves or stays in the EU, YouGov seems to be a sound buy.

Contract wins

Meanwhile, aerospace company Cobham (LSE: COB) has today announced that it has been awarded a contract by Airbus to provide satellite communications to single-aisle and long-range aircraft families. The contract could be worth as much as $200m and will see aircraft being fitted with the communications technology from 2018 onwards. It’s the second major contract Cobham has won with Airbus in the last two months.

Clearly, Cobham has experienced a challenging period of late and its bottom line is due to fall by 22% this year. However, with it being geographically highly diversified and more reliant on the global economy than the UK economy, its return to growth next year seems to be less dependent on the outcome of today’s referendum than is the case for a number of its index peers. And with it trading on a price-to-earnings (P/E) ratio of 11.9, it seems to offer a sufficiently wide margin of safety to merit investment at the present time.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 Warren Buffett investing ideas I plan to use in 2026

After decades in the top job at Berkshire Hathaway, Warren Buffett is preparing to step aside. But this writer will…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

Looking to earn a second income next year (and every year)? Here’s one approach.

Christopher Ruane explains how some prudent investment decisions now could potentially help set someone up with a second income in…

Read more »

Senior woman potting plant in garden at home
Investing Articles

Could a 10%+ yielding dividend share like this make sense for a retirement portfolio?

With a double-digit percentage yield, could this FTSE 250 share be worth considering for a retirement portfolio? Our writer weighs…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Forget Rigetti and IonQ: here’s a quantum computing growth stock that actually looks cheap

Edward Sheldon has found a growth stock in the quantum computing space with lots of potential and a really attractive…

Read more »

UK money in a Jar on a background
Investing Articles

Here’s a £3 a day passive income plan for 2026!

Looking for a simple and cheap plan to try and earn passive income in 2026 and beyond? Christopher Ruane shares…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

NIO stock’s down 35% since October. Time to buy?

NIO stock has had a roller coaster year so far! Christopher Ruane looks at some of the highs and lows…

Read more »

Investing Articles

By December 2026, £1,000 invested in BAE Systems shares could be worth…

Where will BAE Systems shares be in a year's time? Here is our Foolish author's review of the latest analyst…

Read more »

Mature people enjoying time together during road trip
Investing Articles

Keen for early retirement with a second income from dividends? Here’s how much you might need to invest

Ditching the office job early is a dream of many, but without a second income, is it possible? Here’s how…

Read more »